BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 32335999)

  • 1. Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice.
    Hedegger K; Algül H; Lesina M; Blutke A; Schmid RM; Schneider MR; Dahlhoff M
    Mol Oncol; 2020 Aug; 14(8):1653-1669. PubMed ID: 32335999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential impact of the ERBB receptors EGFR and ERBB2 on the initiation of precursor lesions of pancreatic ductal adenocarcinoma.
    Meyers N; Gérard C; Lemaigre FP; Jacquemin P
    Sci Rep; 2020 Mar; 10(1):5241. PubMed ID: 32251323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma.
    Hedegger K; Blutke A; Hommel T; Auer KE; Nataraj NB; Lindzen M; Yarden Y; Dahlhoff M
    Mol Oncol; 2023 Nov; 17(11):2415-2431. PubMed ID: 37341059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2.
    Riese DJ; Komurasaki T; Plowman GD; Stern DF
    J Biol Chem; 1998 May; 273(18):11288-94. PubMed ID: 9556621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of betacellulin against acute pancreatitis is ERBB4 dependent.
    Hedegger K; Stumpf F; Blum H; Graf A; Schmid RM; Lesina M; Algül H; Schneider MR; Dahlhoff M
    J Gastroenterol; 2020 Mar; 55(3):317-329. PubMed ID: 31456099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
    Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB
    Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models.
    Mahajan UM; Li Q; Alnatsha A; Maas J; Orth M; Maier SH; Peterhansl J; Regel I; Sendler M; Wagh PR; Mishra N; Xue Y; Allawadhi P; Beyer G; Kühn JP; Marshall T; Appel B; Lämmerhirt F; Belka C; Müller S; Weiss FU; Lauber K; Lerch MM; Mayerle J
    Gastroenterology; 2021 Sep; 161(3):996-1010.e1. PubMed ID: 34097885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
    Ijichi H; Chytil A; Gorska AE; Aakre ME; Fujitani Y; Fujitani S; Wright CV; Moses HL
    Genes Dev; 2006 Nov; 20(22):3147-60. PubMed ID: 17114585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betacellulin transgenic mice develop urothelial hyperplasia and show sex-dependent reduction in urinary major urinary protein content.
    Schulz H; Dahlhoff M; Glogowska A; Zhang L; Arnold GJ; Fröhlich T; Schneider MR; Klonisch T
    Exp Mol Pathol; 2015 Aug; 99(1):33-8. PubMed ID: 25943456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
    Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
    Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction of betacellulin in growth and migration of vascular smooth muscle cells.
    Mifune M; Ohtsu H; Suzuki H; Frank GD; Inagami T; Utsunomiya H; Dempsey PJ; Eguchi S
    Am J Physiol Cell Physiol; 2004 Sep; 287(3):C807-13. PubMed ID: 15163624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
    Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y
    Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Betacellulin (BTC) Biases the EGFR To Dimerize with ErbB3.
    Rush JS; Peterson JL; Ceresa BP
    Mol Pharmacol; 2018 Dec; 94(6):1382-1390. PubMed ID: 30249613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betacellulin and amphiregulin induce upregulation of cyclin D1 and DNA synthesis activity through differential signaling pathways in vascular smooth muscle cells.
    Shin HS; Lee HJ; Nishida M; Lee MS; Tamura R; Yamashita S; Matsuzawa Y; Lee IK; Koh GY
    Circ Res; 2003 Aug; 93(4):302-10. PubMed ID: 12869389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer.
    Zhang S; Chung WC; Xu K
    Oncogene; 2016 May; 35(19):2485-95. PubMed ID: 26279302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Betacellulin-induced beta cell proliferation and regeneration is mediated by activation of ErbB-1 and ErbB-2 receptors.
    Oh YS; Shin S; Lee YJ; Kim EH; Jun HS
    PLoS One; 2011; 6(8):e23894. PubMed ID: 21897861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.